To investigate the possible associations between the protein levels of CBFB and SMARCC1 and the TNM stages and overall survival, IHC was applied to a large custom-made TMA with stage I–III adenocarcinomas for which follow-up information was available. This evidence concerns the gene SMARCC1 and adenocarcinoma.